Henlius Biopharmaceuticals Inc Fremont, CA - 94538

Henlius Biopharmaceuticals Inc is categorized under Research Services in Fremont, CA and active since 2010.

Henlius Biopharmaceuticals Inc was established in 2010, and today employs 1 to 4, earning Unknown per year. This is a Research Services business, which does work in the B2B market, and is classified as a Research Services, under code number 5417110 by the NAICS.

If you are seeking more information, feel free to contact Scott Liu, Chief Executive Officer at the company’s single location by writing to 48860 Milmont Drive # 107c, Fremont, California CA 94538 or by phoning (510) 445-0305. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Henlius Biopharmaceuticals Inc
Contact Person: Scott Liu, Chief Executive Officer
Address: 48860 Milmont Drive # 107c, Fremont, California 94538
Phone Number: (510) 445-0305
Website Address: henliusbio.com
Annual Revenue (USD): Unknown
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Research Services
SIC Code: 8732
NAICS Code: 5417110
Share This Business:

Henlius Biopharmaceuticals Inc was started in 2010 to provide professional Research Services under the SIC code 8732 and NAICS code 5417110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Scott Liu, Chief Executive Officer for inquiries that concern Henlius Biopharmaceuticals Inc by calling the company number (510) 445-0305, as your correspondence is most welcome. Additionally, the physical location of the single location of Henlius Biopharmaceuticals Inc can be found at the coordinates 37.46115,-121.92182 as well as the street address 48860 Milmont Drive # 107c in Fremont, California 94538.

For its online presence, you may visit Henlius Biopharmaceuticals Inc’s website at henliusbio.com and engage with its social media outlets through on Twitter and on Facebook.